Pliant Therapeutics (PLRX) Preferred Dividend Payments (2019 - 2020)

Pliant Therapeutics (PLRX) reported Preferred Dividend Payments of $11.0 million for Q1 2020, up 207.05% quarter-over-quarter from -$10.3 million in Q4 2019.

Pliant Therapeutics (PLRX) Preferred Dividend Payments (2019 - 2020) Analysis & Trends

Pliant Therapeutics (PLRX) has 2 years of Preferred Dividend Payments data on file, last reported at $11.0 million in Q1 2020.

  • Preferred Dividend Payments for Q1 2020 came in at $11.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $2.1 million (down 39.28% YoY), and the FY2019 annual result was -$6.2 million, changed N/A from the prior year.
  • Preferred Dividend Payments climbed to $11.0 million in Q1 2020 per PLRX's latest filing, from -$10.3 million in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $11.0 million in Q1 2020 and troughed at -$10.3 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Pliant Therapeutics 71.07 Mn 71.07 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 11.03 Mn
Dec 31, 2019 -10.30 Mn
Sep 30, 2019 1.38 Mn
Jun 30, 2019 1.36 Mn